Trial Profile
Cross-sectional study investigating the effect of Remicade (infliximab) administration on T-regulatory lymphocytes in children with ulcerative colitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Pharmacodynamics
- 18 Dec 2015 New trial record